ATE93144T1 - Methode zur verminderung der immunglobulin-ereaktion. - Google Patents

Methode zur verminderung der immunglobulin-ereaktion.

Info

Publication number
ATE93144T1
ATE93144T1 AT89300872T AT89300872T ATE93144T1 AT E93144 T1 ATE93144 T1 AT E93144T1 AT 89300872 T AT89300872 T AT 89300872T AT 89300872 T AT89300872 T AT 89300872T AT E93144 T1 ATE93144 T1 AT E93144T1
Authority
AT
Austria
Prior art keywords
ereaction
reducing immunoglobulin
antagonist
human interleukin
immunoglobulin
Prior art date
Application number
AT89300872T
Other languages
English (en)
Inventor
Robert L Coffman
Vries Jan Egbert De
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22538655&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE93144(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Application granted granted Critical
Publication of ATE93144T1 publication Critical patent/ATE93144T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89300872T 1988-02-02 1989-01-30 Methode zur verminderung der immunglobulin-ereaktion. ATE93144T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15141388A 1988-02-02 1988-02-02
EP89300872A EP0327283B1 (de) 1988-02-02 1989-01-30 Methode zur Verminderung der Immunglobulin-E-Reaktion

Publications (1)

Publication Number Publication Date
ATE93144T1 true ATE93144T1 (de) 1993-09-15

Family

ID=22538655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89300872T ATE93144T1 (de) 1988-02-02 1989-01-30 Methode zur verminderung der immunglobulin-ereaktion.

Country Status (20)

Country Link
US (1) US5676940A (de)
EP (2) EP0327283B1 (de)
JP (1) JPH03500050A (de)
KR (1) KR900700132A (de)
AT (1) ATE93144T1 (de)
AU (1) AU629536B2 (de)
CA (1) CA1341477C (de)
DE (1) DE68908431T2 (de)
DK (1) DK183590A (de)
ES (1) ES2058490T3 (de)
FI (1) FI903827A0 (de)
HK (1) HK35196A (de)
HU (1) HU211059B (de)
IE (1) IE63097B1 (de)
IL (1) IL89124A (de)
MY (1) MY107079A (de)
NZ (1) NZ227812A (de)
PT (1) PT89573B (de)
WO (1) WO1989006975A1 (de)
ZA (1) ZA89766B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
DK0504307T3 (da) * 1989-12-04 1994-03-21 Schering Corp Fremgangsmåde til behandling af septisk shock
PT96230B (pt) * 1989-12-20 1998-06-30 Schering Corp Processo para a producao de um polipeptideo e anticorpos antagonistas da interleuquina-4 humana
US5252677A (en) * 1990-11-20 1993-10-12 Mitsubishi Petrochemical Company Limited Functionalized olefin polymers
DE4137333A1 (de) * 1991-11-13 1993-05-19 W Prof Dr Sebald Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung
US5914110A (en) * 1993-09-07 1999-06-22 Smithkline Beecham Corporation Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5928904A (en) * 1993-09-07 1999-07-27 Smithkline Beecham Corporation DNA encoding recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US20020193575A1 (en) * 1993-09-07 2002-12-19 Smithkline Beecham P.L.C. Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
US5597710A (en) * 1994-03-10 1997-01-28 Schering Corporation Humanized monoclonal antibodies against human interleukin-4
US6919366B2 (en) 1998-05-22 2005-07-19 Avanir Pharmaceuticals Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) 1998-05-22 2005-06-28 Avanir Pharmaceuticals Benzimidazole compounds for regulating IgE
US6759425B2 (en) 1999-10-21 2004-07-06 Avanir Pharmaceuticals Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
DE16192152T1 (de) 2000-05-26 2020-08-06 Immunex Corporation Verwendung von interleukin-4 rezeptor (il-4r) antikörpern und zusammensetzungen davon
DE60221804T2 (de) 2001-03-12 2008-05-15 Avanir Pharmaceuticals, San Diego Benzimidazolderivate zur ige-modulierung und zellproliferationshemmung
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
WO2004024655A2 (en) 2002-09-12 2004-03-25 Avanir Pharmaceuticals Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
AR050044A1 (es) 2004-08-03 2006-09-20 Novartis Ag Anticuerpo especifico de il-4
US10196616B2 (en) 2017-02-15 2019-02-05 The United States Of America, As Represented By The Secretary Of Agriculture Altered avian virus for in-ovo inoculation and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041381A (en) * 1986-07-03 1991-08-20 Schering Corporation Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
PT83761B (pt) * 1985-11-19 1989-06-30 Schering Biotech Corp Metodo para a producao de interleuquina-4 de mamifero
US5017691A (en) * 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
EP0255547A1 (de) * 1986-07-29 1988-02-10 Kishimoto, Tadamitsu, Prof. Monoklonale Antikörper spezifisch gegen Oberflächen-IgE-Rezeptor, sowie Hybrid-Zellinien zur Herstellung und Verwendung dieser Antikörper
WO1989006138A1 (en) * 1987-12-31 1989-07-13 Tanox Biosystems, Inc. UNIQUE ANTIGENIC EPITOPES ON IgE-BEARING B LYMPHOCYTES

Also Published As

Publication number Publication date
IL89124A0 (en) 1989-08-15
AU3038389A (en) 1989-08-25
ZA89766B (en) 1989-09-27
HU891044D0 (en) 1990-11-28
CA1341477C (en) 2005-03-29
PT89573A (pt) 1989-10-04
IL89124A (en) 1994-10-21
DE68908431T2 (de) 1993-12-23
HUT54214A (en) 1991-01-28
PT89573B (pt) 1994-01-31
JPH03500050A (ja) 1991-01-10
FI903827A7 (fi) 1990-08-01
ES2058490T3 (es) 1994-11-01
MY107079A (en) 1995-09-30
FI903827A0 (fi) 1990-08-01
EP0397764A1 (de) 1990-11-22
US5676940A (en) 1997-10-14
AU629536B2 (en) 1992-10-08
KR900700132A (ko) 1990-08-11
IE63097B1 (en) 1995-03-22
DK183590A (da) 1990-09-27
DE68908431D1 (de) 1993-09-23
DK183590D0 (da) 1990-08-01
IE890302L (en) 1989-08-02
HU211059B (en) 1995-10-30
NZ227812A (en) 1991-09-25
EP0327283A1 (de) 1989-08-09
EP0327283B1 (de) 1993-08-18
WO1989006975A1 (en) 1989-08-10
HK35196A (en) 1996-03-08

Similar Documents

Publication Publication Date Title
ATE93144T1 (de) Methode zur verminderung der immunglobulin-ereaktion.
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
DK388384A (da) Monoklone antistoffer med specifitet for membran-associerede antigener, deres fremstilling og anvendelse
EP0216454A3 (en) Method of promoting animal growth
ATE98872T1 (de) Antagonist fuer interleukin-5 zur verhuetung oder verminderung von eosinophilie.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
FI922551A0 (fi) Foerfarande foer skoetsel av septisk chock.
KR890700832A (ko) 그람 음성균의 항원 결정기와 결합하는 사람 단일클론성 항체
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
DK134487D0 (da) Monoklonalt antistof med affinitet for humant interleukin-2
FI924278A0 (fi) Bcrf1 antagonister foer skoetsel av epstein-barr-virusinfektioner.
ES536028A0 (es) Un procedimiento para producir interferon inmune humano recombinante intacto
ATE59860T1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
FI924851A7 (fi) Monoklonaalisia IgM:n vastaisia vasta-aineita, niiden tuottaminen ja k äyttö sekä hybridoomia näiden tuottamista varten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
RZN Patent revoked